Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
申请人:Miller Scott
公开号:US20080269265A1
公开(公告)日:2008-10-30
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
这项发明涉及使用一组芳基脲类化合物治疗raf介导的疾病,以及用于该疗法的药物组合物。